SCHEMBL4903085

SCHEMBL4903085

CCN(c1nc(-c2ccc(C(F)(F)F)cc2)sc1C)S(=O)(=O)c1ccc(C(C)C)c(C(=O)OC)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HSP90AA1 P07900 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40
PPARA Q07869 4/20 0.39
PPARD Q03181 2/20 0.39
PPARG P37231 1/20 0.39
ALDH1A1 P00352 2/20 0.38
TSHR P16473 1/20 0.38
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37
RORC P51449 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC11 Q96DB2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4895904 0.93 ALDH1A1 (0.39) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4903915 0.91 TRPM8 (0.44) KDM4EALDH1A1TRPM8RORC
SCHEMBL4898146 0.91 LMNA (0.41) GAAMEN1MAPTKMT2AKDM4E
SCHEMBL4905630 0.91 ALDH1A1 (0.40) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4903740 0.91 ALDH1A1 (0.41) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4905533 0.90 KDM4E (0.42) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4900703 0.89 KDM4E (0.41) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4905738 0.89 ALDH1A1 (0.44) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4906349 0.89 ALDH1A1 (0.50) GAAL3MBTL1MEN1MAPTKMT2A
SCHEMBL4894604 0.86 ALDH1A1 (0.43) GAAL3MBTL1MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD GAA 1383/4885L3MBTL1 1234/4885MEN1 4859/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD GAA 1367/4885L3MBTL1 1246/4885MEN1 4855/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD GAA 1367/4885L3MBTL1 1246/4885MEN1 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.